Adoptive Cell Therapy Market Size, Share, Price, Trend and Forecast 2022 to 2028

Market Analysis and Insights: Global Adoptive Cell Therapy Market

The global Adoptive Cell Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Adoptive Cell Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Adoptive Cell Therapy market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Adoptive Cell Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Adoptive Cell Therapy market.

Global Adoptive Cell Therapy Scope and Market Size

Adoptive Cell Therapy market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Adoptive Cell Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2029.
Segment by Type
CAR-T
TCR-T
NK
TIL
Segment by Application
Lymphoma
Leukemia
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Novartis
Juno
Kite
Adaptimmune
Fibrocell
Lineage Cell Therapeutics
BioTime
Vericel Corporation
Regeneus
Anhui Anke Biotechnology
Cellectis
NantKwest
SorrentoTherapeutics
Bellicum

The information for each competitor/Company Profile includes:

Company Overview
Business Strategy
Key Product Offerings
Financial Performance
Key Performance Indicators
Risk Analysis
Recent Development
Regional Presence
SWOT Analysis

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Adoptive Cell Therapy product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Adoptive Cell Therapy, with price, sales, revenue, and global market share of Adoptive Cell Therapy from 2019 to 2022.

Chapter 3, the Adoptive Cell Therapy competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Adoptive Cell Therapy breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Adoptive Cell Therapy market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Adoptive Cell Therapy.

Chapter 13, 14, and 15, to describe Adoptive Cell Therapy sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

Estimates 2022-2027 2021-2025 Adoptive Cell Therapy Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
Market dynamics scenario, along with growth opportunities of the market in the years to come
Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adoptive Cell Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 CAR-T
1.2.3 TCR-T
1.2.4 NK
1.2.5 TIL
1.3 Market by Application
1.3.1 Global Adoptive Cell Therapy Market Share by Application: 2018 VS 2022 VS 2029
1.3.2 Lymphoma
1.3.3 Leukemia
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Adoptive Cell Therapy Market Perspective (2018-2029)
2.2 Adoptive Cell Therapy Growth Trends by Region
2.2.1 Adoptive Cell Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Adoptive Cell Therapy Historic Market Size by Region (2018-2023)
2.2.3 Adoptive Cell Therapy Forecasted Market Size by Region (2024-2029)
2.3 Adoptive Cell Therapy Market Dynamics
2.3.1 Adoptive Cell Therapy Industry Trends
2.3.2 Adoptive Cell Therapy Market Drivers
2.3.3 Adoptive Cell Therapy Market Challenges
2.3.4 Adoptive Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Adoptive Cell Therapy Players by Revenue
3.1.1 Global Top Adoptive Cell Therapy Players by Revenue (2018-2023)
3.1.2 Global Adoptive Cell Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Adoptive Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Adoptive Cell Therapy Revenue
3.4 Global Adoptive Cell Therapy Market Concentration Ratio
3.4.1 Global Adoptive Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adoptive Cell Therapy Revenue in 2022
3.5 Adoptive Cell Therapy Key Players Head office and Area Served
3.6 Key Players Adoptive Cell Therapy Product Solution and Service
3.7 Date of Enter into Adoptive Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Adoptive Cell Therapy Breakdown Data by Type
4.1 Global Adoptive Cell Therapy Historic Market Size by Type (2018-2023)
4.2 Global Adoptive Cell Therapy Forecasted Market Size by Type (2024-2029)
5 Adoptive Cell Therapy Breakdown Data by Application
5.1 Global Adoptive Cell Therapy Historic Market Size by Application (2018-2023)
5.2 Global Adoptive Cell Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Adoptive Cell Therapy Market Size (2018-2029)
6.2 North America Adoptive Cell Therapy Market Size by Country (2018-2023)
6.3 North America Adoptive Cell Therapy Market Size by Country (2024-2029)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Adoptive Cell Therapy Market Size (2018-2029)
7.2 Europe Adoptive Cell Therapy Market Size by Country (2018-2023)
7.3 Europe Adoptive Cell Therapy Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Adoptive Cell Therapy Market Size (2018-2029)
8.2 Asia-Pacific Adoptive Cell Therapy Market Size by Country (2018-2023)
8.3 Asia-Pacific Adoptive Cell Therapy Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Adoptive Cell Therapy Market Size (2018-2029)
9.2 Latin America Adoptive Cell Therapy Market Size by Country (2018-2023)
9.3 Latin America Adoptive Cell Therapy Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Adoptive Cell Therapy Market Size (2018-2029)
10.2 Middle East & Africa Adoptive Cell Therapy Market Size by Country (2018-2023)
10.3 Middle East & Africa Adoptive Cell Therapy Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Adoptive Cell Therapy Introduction
11.1.4 Novartis Revenue in Adoptive Cell Therapy Business (2018-2023)
11.1.5 Novartis Recent Development
11.2 Juno
11.2.1 Juno Company Detail
11.2.2 Juno Business Overview
11.2.3 Juno Adoptive Cell Therapy Introduction
11.2.4 Juno Revenue in Adoptive Cell Therapy Business (2018-2023)
11.2.5 Juno Recent Development
11.3 Kite
11.3.1 Kite Company Detail
11.3.2 Kite Business Overview
11.3.3 Kite Adoptive Cell Therapy Introduction
11.3.4 Kite Revenue in Adoptive Cell Therapy Business (2018-2023)
11.3.5 Kite Recent Development
11.4 Adaptimmune
11.4.1 Adaptimmune Company Detail
11.4.2 Adaptimmune Business Overview
11.4.3 Adaptimmune Adoptive Cell Therapy Introduction
11.4.4 Adaptimmune Revenue in Adoptive Cell Therapy Business (2018-2023)
11.4.5 Adaptimmune Recent Development
11.5 Fibrocell
11.5.1 Fibrocell Company Detail
11.5.2 Fibrocell Business Overview
11.5.3 Fibrocell Adoptive Cell Therapy Introduction
11.5.4 Fibrocell Revenue in Adoptive Cell Therapy Business (2018-2023)
11.5.5 Fibrocell Recent Development
11.6 Lineage Cell Therapeutics
11.6.1 Lineage Cell Therapeutics Company Detail
11.6.2 Lineage Cell Therapeutics Business Overview
11.6.3 Lineage Cell Therapeutics Adoptive Cell Therapy Introduction
11.6.4 Lineage Cell Therapeutics Revenue in Adoptive Cell Therapy Business (2018-2023)
11.6.5 Lineage Cell Therapeutics Recent Development
11.7 BioTime
11.7.1 BioTime Company Detail
11.7.2 BioTime Business Overview
11.7.3 BioTime Adoptive Cell Therapy Introduction
11.7.4 BioTime Revenue in Adoptive Cell Therapy Business (2018-2023)
11.7.5 BioTime Recent Development
11.8 Vericel Corporation
11.8.1 Vericel Corporation Company Detail
11.8.2 Vericel Corporation Business Overview
11.8.3 Vericel Corporation Adoptive Cell Therapy Introduction
11.8.4 Vericel Corporation Revenue in Adoptive Cell Therapy Business (2018-2023)
11.8.5 Vericel Corporation Recent Development
11.9 Regeneus
11.9.1 Regeneus Company Detail
11.9.2 Regeneus Business Overview
11.9.3 Regeneus Adoptive Cell Therapy Introduction
11.9.4 Regeneus Revenue in Adoptive Cell Therapy Business (2018-2023)
11.9.5 Regeneus Recent Development
11.10 Anhui Anke Biotechnology
11.10.1 Anhui Anke Biotechnology Company Detail
11.10.2 Anhui Anke Biotechnology Business Overview
11.10.3 Anhui Anke Biotechnology Adoptive Cell Therapy Introduction
11.10.4 Anhui Anke Biotechnology Revenue in Adoptive Cell Therapy Business (2018-2023)
11.10.5 Anhui Anke Biotechnology Recent Development
11.11 Cellectis
11.11.1 Cellectis Company Detail
11.11.2 Cellectis Business Overview
11.11.3 Cellectis Adoptive Cell Therapy Introduction
11.11.4 Cellectis Revenue in Adoptive Cell Therapy Business (2018-2023)
11.11.5 Cellectis Recent Development
11.12 NantKwest
11.12.1 NantKwest Company Detail
11.12.2 NantKwest Business Overview
11.12.3 NantKwest Adoptive Cell Therapy Introduction
11.12.4 NantKwest Revenue in Adoptive Cell Therapy Business (2018-2023)
11.12.5 NantKwest Recent Development
11.13 SorrentoTherapeutics
11.13.1 SorrentoTherapeutics Company Detail
11.13.2 SorrentoTherapeutics Business Overview
11.13.3 SorrentoTherapeutics Adoptive Cell Therapy Introduction
11.13.4 SorrentoTherapeutics Revenue in Adoptive Cell Therapy Business (2018-2023)
11.13.5 SorrentoTherapeutics Recent Development
11.14 Bellicum
11.14.1 Bellicum Company Detail
11.14.2 Bellicum Business Overview
11.14.3 Bellicum Adoptive Cell Therapy Introduction
11.14.4 Bellicum Revenue in Adoptive Cell Therapy Business (2018-2023)
11.14.5 Bellicum Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Adoptive Cell Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of CAR-T
Table 3. Key Players of TCR-T
Table 4. Key Players of NK
Table 5. Key Players of TIL
Table 6. Global Adoptive Cell Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Adoptive Cell Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Adoptive Cell Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Adoptive Cell Therapy Market Share by Region (2018-2023)
Table 10. Global Adoptive Cell Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Adoptive Cell Therapy Market Share by Region (2024-2029)
Table 12. Adoptive Cell Therapy Market Trends
Table 13. Adoptive Cell Therapy Market Drivers
Table 14. Adoptive Cell Therapy Market Challenges
Table 15. Adoptive Cell Therapy Market Restraints
Table 16. Global Adoptive Cell Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Adoptive Cell Therapy Market Share by Players (2018-2023)
Table 18. Global Top Adoptive Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adoptive Cell Therapy as of 2022)
Table 19. Ranking of Global Top Adoptive Cell Therapy Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Adoptive Cell Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Adoptive Cell Therapy Product Solution and Service
Table 23. Date of Enter into Adoptive Cell Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Adoptive Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Adoptive Cell Therapy Revenue Market Share by Type (2018-2023)
Table 27. Global Adoptive Cell Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Adoptive Cell Therapy Revenue Market Share by Type (2024-2029)
Table 29. Global Adoptive Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Adoptive Cell Therapy Revenue Market Share by Application (2018-2023)
Table 31. Global Adoptive Cell Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Adoptive Cell Therapy Revenue Market Share by Application (2024-2029)
Table 33. North America Adoptive Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Adoptive Cell Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Adoptive Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Adoptive Cell Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Adoptive Cell Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Adoptive Cell Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 39. Latin America Adoptive Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 40. Latin America Adoptive Cell Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 41. Middle East & Africa Adoptive Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 42. Middle East & Africa Adoptive Cell Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 43. Novartis Company Detail
Table 44. Novartis Business Overview
Table 45. Novartis Adoptive Cell Therapy Product
Table 46. Novartis Revenue in Adoptive Cell Therapy Business (2018-2023) & (US$ Million)
Table 47. Novartis Recent Development
Table 48. Juno Company Detail
Table 49. Juno Business Overview
Table 50. Juno Adoptive Cell Therapy Product
Table 51. Juno Revenue in Adoptive Cell Therapy Business (2018-2023) & (US$ Million)
Table 52. Juno Recent Development
Table 53. Kite Company Detail
Table 54. Kite Business Overview
Table 55. Kite Adoptive Cell Therapy Product
Table 56. Kite Revenue in Adoptive Cell Therapy Business (2018-2023) & (US$ Million)
Table 57. Kite Recent Development
Table 58. Adaptimmune Company Detail
Table 59. Adaptimmune Business Overview
Table 60. Adaptimmune Adoptive Cell Therapy Product
Table 61. Adaptimmune Revenue in Adoptive Cell Therapy Business (2018-2023) & (US$ Million)
Table 62. Adaptimmune Recent Development
Table 63. Fibrocell Company Detail
Table 64. Fibrocell Business Overview
Table 65. Fibrocell Adoptive Cell Therapy Product
Table 66. Fibrocell Revenue in Adoptive Cell Therapy Business (2018-2023) & (US$ Million)
Table 67. Fibrocell Recent Development
Table 68. Lineage Cell Therapeutics Company Detail
Table 69. Lineage Cell Therapeutics Business Overview
Table 70. Lineage Cell Therapeutics Adoptive Cell Therapy Product
Table 71. Lineage Cell Therapeutics Revenue in Adoptive Cell Therapy Business (2018-2023) & (US$ Million)
Table 72. Lineage Cell Therapeutics Recent Development
Table 73. BioTime Company Detail
Table 74. BioTime Business Overview
Table 75. BioTime Adoptive Cell Therapy Product
Table 76. BioTime Revenue in Adoptive Cell Therapy Business (2018-2023) & (US$ Million)
Table 77. BioTime Recent Development
Table 78. Vericel Corporation Company Detail
Table 79. Vericel Corporation Business Overview
Table 80. Vericel Corporation Adoptive Cell Therapy Product
Table 81. Vericel Corporation Revenue in Adoptive Cell Therapy Business (2018-2023) & (US$ Million)
Table 82. Vericel Corporation Recent Development
Table 83. Regeneus Company Detail
Table 84. Regeneus Business Overview
Table 85. Regeneus Adoptive Cell Therapy Product
Table 86. Regeneus Revenue in Adoptive Cell Therapy Business (2018-2023) & (US$ Million)
Table 87. Regeneus Recent Development
Table 88. Anhui Anke Biotechnology Company Detail
Table 89. Anhui Anke Biotechnology Business Overview
Table 90. Anhui Anke Biotechnology Adoptive Cell Therapy Product
Table 91. Anhui Anke Biotechnology Revenue in Adoptive Cell Therapy Business (2018-2023) & (US$ Million)
Table 92. Anhui Anke Biotechnology Recent Development
Table 93. Cellectis Company Detail
Table 94. Cellectis Business Overview
Table 95. Cellectis Adoptive Cell TherapyProduct
Table 96. Cellectis Revenue in Adoptive Cell Therapy Business (2018-2023) & (US$ Million)
Table 97. Cellectis Recent Development
Table 98. NantKwest Company Detail
Table 99. NantKwest Business Overview
Table 100. NantKwest Adoptive Cell TherapyProduct
Table 101. NantKwest Revenue in Adoptive Cell Therapy Business (2018-2023) & (US$ Million)
Table 102. NantKwest Recent Development
Table 103. SorrentoTherapeutics Company Detail
Table 104. SorrentoTherapeutics Business Overview
Table 105. SorrentoTherapeutics Adoptive Cell TherapyProduct
Table 106. SorrentoTherapeutics Revenue in Adoptive Cell Therapy Business (2018-2023) & (US$ Million)
Table 107. SorrentoTherapeutics Recent Development
Table 108. Bellicum Company Detail
Table 109. Bellicum Business Overview
Table 110. Bellicum Adoptive Cell TherapyProduct
Table 111. Bellicum Revenue in Adoptive Cell Therapy Business (2018-2023) & (US$ Million)
Table 112. Bellicum Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Adoptive Cell Therapy Market Share by Type: 2022 VS 2029
Figure 2. CAR-T Features
Figure 3. TCR-T Features
Figure 4. NK Features
Figure 5. TIL Features
Figure 6. Global Adoptive Cell Therapy Market Share by Application in 2022 & 2029
Figure 7. Lymphoma Case Studies
Figure 8. Leukemia Case Studies
Figure 9. Adoptive Cell Therapy Report Years Considered
Figure 10. Global Adoptive Cell Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global Adoptive Cell Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Adoptive Cell Therapy Market Share by Region: 2022 VS 2029
Figure 13. Global Adoptive Cell Therapy Market Share by Players in 2022
Figure 14. Global Top Adoptive Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adoptive Cell Therapy as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Adoptive Cell Therapy Revenue in 2022
Figure 16. North America Adoptive Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America Adoptive Cell Therapy Market Share by Country (2018-2029)
Figure 18. United States Adoptive Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. Canada Adoptive Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Europe Adoptive Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Adoptive Cell Therapy Market Share by Country (2018-2029)
Figure 22. Germany Adoptive Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. France Adoptive Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. U.K. Adoptive Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Italy Adoptive Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Russia Adoptive Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Nordic Countries Adoptive Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Asia-Pacific Adoptive Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Adoptive Cell Therapy Market Share by Region (2018-2029)
Figure 30. China Adoptive Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Japan Adoptive Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. South Korea Adoptive Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Southeast Asia Adoptive Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. India Adoptive Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Australia Adoptive Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Latin America Adoptive Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Adoptive Cell Therapy Market Share by Country (2018-2029)
Figure 38. Mexico Adoptive Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Brazil Adoptive Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Middle East & Africa Adoptive Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Adoptive Cell Therapy Market Share by Country (2018-2029)
Figure 42. Turkey Adoptive Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Saudi Arabia Adoptive Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Novartis Revenue Growth Rate in Adoptive Cell Therapy Business (2018-2023)
Figure 45. Juno Revenue Growth Rate in Adoptive Cell Therapy Business (2018-2023)
Figure 46. Kite Revenue Growth Rate in Adoptive Cell Therapy Business (2018-2023)
Figure 47. Adaptimmune Revenue Growth Rate in Adoptive Cell Therapy Business (2018-2023)
Figure 48. Fibrocell Revenue Growth Rate in Adoptive Cell Therapy Business (2018-2023)
Figure 49. Lineage Cell Therapeutics Revenue Growth Rate in Adoptive Cell Therapy Business (2018-2023)
Figure 50. BioTime Revenue Growth Rate in Adoptive Cell Therapy Business (2018-2023)
Figure 51. Vericel Corporation Revenue Growth Rate in Adoptive Cell Therapy Business (2018-2023)
Figure 52. Regeneus Revenue Growth Rate in Adoptive Cell Therapy Business (2018-2023)
Figure 53. Anhui Anke Biotechnology Revenue Growth Rate in Adoptive Cell Therapy Business (2018-2023)
Figure 54. Cellectis Revenue Growth Rate in Adoptive Cell Therapy Business (2018-2023)
Figure 55. NantKwest Revenue Growth Rate in Adoptive Cell Therapy Business (2018-2023)
Figure 56. SorrentoTherapeutics Revenue Growth Rate in Adoptive Cell Therapy Business (2018-2023)
Figure 57. Bellicum Revenue Growth Rate in Adoptive Cell Therapy Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

DOWNLOAD SAMPLE

Download
Free Sample

Request
Customization

Check
Discount

Offer REPORT BUYING OPTIONS

Single User Price : $1611

Multi User Price : $2417

Enterprise Price : $3222

---- OR ----

Frequently Asked Questions ?

Delivery Time

Upto 24 hrs - Working days
Upto 48 hrs max - Weekends and public holidays

User License

Single User License
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

Multi user License
A license granted to multiple users.

Site License
A license granted to a single business site/establishment.

Corporate License, Global License
A license granted to all employees within organisation access to the product.

Payment Options

Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer

Report Delivery

Email
Hard Copy

Our Key Features

Data Accuracy and Reliability
Data Security
Customized Research
Trustworthy
Competitive Offerings

Global Adoptive Cell Therapy Market Research Report 2023

TABLE OF CONTENTS